Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Interpore’s $30 Mil. Spinal Business Provides Backbone For Growth

This article was originally published in The Gray Sheet

Executive Summary

Interpore Cross International's C-TEK anterior cervical plate and Synergy lower back and deformity systems are driving a big jump in the company's spinal product line: sales of spinal products climbed 49% to $8.4 mil. in the final quarter of 2001

You may also be interested in...

Interpore Cross

Spinal implant maker will acquire AOM-CDO system for placing reinforcing substances inside bony structures such as spinal vertebrae through a $21.3 mil. agreement with privately held OsteoMedix, announced May 31. Introduced in mid-2000, the minimally invasive device allows treatment of pain from vertebral compression fractures, according to Interpore. Expected to close by July 31, the deal calls for Interpore to pay $8 mil. in cash and about $2.4 mil. in Interpore stock, which closed May 30 at $5.53 per share. AOM had about $1.2 mil. in sales in 2000

India Rare Disease Policy Proposes Crowdfunding But Patients Feel Let Down

Draft policy moots crowdfunding for high-cost rare diseases alongside financial support for those "amenable to one-time treatment" but falls way short of some patient groups' expectations.

India’s Hilleman Plans ‘Affordable’ Vaccine Against Group B Strep

India’s Hilleman Laboratories says it’s aiming to develop an affordable vaccine that will target pregnant women in low- and middle-income countries to prevent Group B Streptococcus, a potentially fatal infection passed to babies during childbirth.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts